Composition for inactivating an enveloped virus
AssigneeViroblock S.A.
InventorsThierry Pelet, Donald F. H. Wallach
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the field of prevention of diseases caused by enveloped viruses. More particularly, this invention concerns a composition for inactivating an enveloped virus comprising at least one non phospholipid Lipid Vesicle (nPLV) able to interact with said enveloped virus and an agent that enhances the lipid exchange between said nPLV and the membrane of said enveloped virus.
Claims23
A composition for inactivating an enveloped virus comprising at least one non-phospholipid Lipid Vesicle (nPLV) able to interact with said enveloped virus and β-cyclodextrin or 2-hydroxypropyl-β-cyclodextrin that enhances the lipid exchange between said nPLV and the membrane of said enveloped virus, wherein the nPLV is cholesterol-free and the concentration of said β-cyclodextrin or 2-hydroxypropyl-β-cyclodextrin in the composition is between 0.01 mM and 10 mM.
Dependencies are inferred from the claim text.